1985•PubMedRequires access

[A highly efficient, highly purified duck embryo rabies vaccine].

Alfred Wegmann, Reinhard Glück, Helen M. Keller, Jean‐Marie Matthieu

Open publisher page 3 citations

Abstract

At the Swiss Serum and Vaccine Institute, Berne, a highly purified rabies vaccine presenting a high content of effective rabies virus glucoprotein antigen has been developed. The new vaccine is derived from embryonated duck eggs (PDEV). Immunizations performed according to the post-exposure schedule recommended for potent rabies vaccines by the WHO (6 injections on days 0, 3, 7, 14, 28 and 90) already induce protective antibody titers on day 14 (greater than 1 IU/ml). Use of the latest radioimmunological methods did not reveal the presence of myelin basic protein in the new rabies vaccine. Due to improvements of its preparation the rabies vaccine PDEV is an economical and highly efficient vaccine involving only a very remote risk of post-vaccinal encephalitis.

About this research paper

What this paper is about

At the Swiss Serum and Vaccine Institute, Berne, a highly purified rabies vaccine presenting a high content of effective rabies virus glucoprotein antigen has been developed. The new vaccine is derived from embryonated duck eggs (PDEV). Immunizations performed according to the post-exposure schedule recommended for potent rabies vaccines by the WHO (6 injections on days 0, 3, 7, 14, 28 and 90) already induce protective antibody titers on day 14 (greater than 1 IU/ml). Use of the latest radioimmunological methods did not reveal the presence of myelin basic protein in the new rabies vaccine. Due to improvements of its preparation the rabies vaccine PDEV is an economical and highly efficient vaccine involving only a very remote risk of post-vaccinal encephalitis.

Why it matters

OpenAlex reports 3 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

At the Swiss Serum and Vaccine Institute, Berne, a highly purified rabies vaccine presenting a high content of effective rabies virus glucoprotein antigen has been developed. The new vaccine is derived from embryonated duck eggs (PDEV). Immunizations performed according to the post-exposure schedule recommended for potent rabies vaccines by the WHO (6 injections on days 0, 3, 7, 14, 28 and 90) already induce protective antibody titers on day 14 (greater than 1 IU/ml). Use of the latest radioimmunological methods did not reveal the presence of myelin basic protein in the new rabies vaccine. Due to improvements of its preparation the rabies vaccine PDEV is an economical and highly efficient vaccine involving only a very remote risk of post-vaccinal encephalitis.

Key concepts: Duck embryo vaccine, Rabies, Rabies vaccine, Embryonated, Virology, Medicine, Titer, Rabies virus

Related papers

Back to paper searchBrowse research topicsOriginal source
[A highly efficient, highly purified duck embryo rabies vaccine]. — Research Paper | ScholarLens